{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:03:45Z","timestamp":1767902625890,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003217.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000}}],"reference-count":139,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003217.pub5","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T17:38:08Z","timestamp":1425490688000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy"],"prefix":"10.1002","volume":"2019","author":[{"given":"T","family":"Umapathi","sequence":"first","affiliation":[{"name":"National Neuroscience Institute; Department of Neurology; 11 Jalan Tan Tock Seng Singapore Singapore 308433"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard AC","family":"Hughes","sequence":"additional","affiliation":[{"name":"National Hospital for Neurology and Neurosurgery; MRC Centre for Neuromuscular Diseases; PO Box 114 Queen Square London UK WC1N 3BG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Nobile-Orazio","sequence":"additional","affiliation":[{"name":"Milan University; IRCCS Humanitas Clinical Institute, Neurology 2; Istituto Clinico Humanitas Via Manzoni 56, Rozzano Milan Italy 20089"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"L\u00e9ger","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Pitrie Salp\u00eatri\u00e8re and University Paris VI; National Reference Center for Rare Neuromuscular Diseases; B\u00e2timent Balinski 47-83 Boulevard de l'H\u00f4pital Paris Cedex 13 France 75651"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"issue":"Pt 8","key":"10.1002\/14651858.CD003217.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/brain\/awm144","article-title":"Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial","volume":"130","author":"Piepers","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1212\/WNL.48.2.544","article-title":"Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis","volume":"48","author":"Abbruzzese","year":"1997","journal-title":"Neurology"},{"issue":"2-3","key":"10.1002\/14651858.CD003217.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1600-0404.2007.00970.x","article-title":"No benefit of treatment with cyclophosphamide and autologous blood stem cell transplantation in multifocal motor neuropathy","volume":"117","author":"Axelson","year":"2008","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD003217.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1212\/WNL.44.3_Part_1.429","article-title":"Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study","volume":"44","author":"Azulay","year":"1994","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jnnp.62.4.391","article-title":"Long term follow up of multifocal motor neuropathy with conduction block under treatment","volume":"62","author":"Azulay","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mus.20024","article-title":"Mycophenolate mofetil in dysimmune neuropathies: a preliminary study","volume":"29","author":"Benedetti","year":"2004","journal-title":"Muscle & Nerve"},{"issue":"1-2","key":"10.1002\/14651858.CD003217.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-510X(99)00219-1","article-title":"Multifocal motor neuropathy mimicking motor neuron disease: nine cases","volume":"169","author":"Bentes","year":"1999","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/(SICI)1097-4598(199806)21:6<813::AID-MUS18>3.0.CO;2-T","article-title":"Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies","volume":"21","author":"Beydoun","year":"1998","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<556::AID-MUS15>3.0.CO;2-G","article-title":"Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block","volume":"23","author":"Beydoun","year":"2000","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp.59.1.38","article-title":"Multifocal motor neuropathy with conduction block: a study of 24 patients","volume":"59","author":"Bouche","year":"1995","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mus.20524","article-title":"High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy","volume":"34","author":"Brannagan","year":"2006","journal-title":"Muscle & Nerve"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.50.5.1480","article-title":"Deterioration of multifocal motor neuropathy after plasma exchange","volume":"50","author":"Carpo","year":"1998","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD003217.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1212\/WNL.0b013e3181f0738e","article-title":"Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy","volume":"75","author":"Cats","year":"2010","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD003217.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.36.9.1260","article-title":"Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome","volume":"36","author":"Chad","year":"1986","journal-title":"Neurology"},{"issue":"8812","key":"10.1002\/14651858.CD003217.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0140-6736(92)93267-Q","article-title":"Intravenous immunoglobulin treatment in multifocal motor neuropathy","volume":"340","author":"Charles","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ana.410330303","article-title":"Multifocal motor neuropathy: response to human immune globulin","volume":"33","author":"Chaudhry","year":"1993","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0018|cit18","first-page":"513","article-title":"Maintenance immune globulin therapy for multifocal motor neuropathy: results of long term follow-up","volume":"40","author":"Chaudhry","year":"1996","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.56.1.94","article-title":"Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases","volume":"56","author":"Chaudhry","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1212\/01.wnl.0000233832.13749.ac","article-title":"Multifocal motor neuropathy: is conduction block essential?","volume":"67","author":"Chaudhry","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1529-8027.2010.00270.x","article-title":"An open-label trial of rituximab (Rituxan\u00ae) in multifocal motor neuropathy","volume":"15","author":"Chaudhry","year":"2010","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1212\/WNL.56.1.97","article-title":"Mycophenolate mofetil for myasthenia gravis: an open-label pilot study","volume":"56","author":"Ciafaloni","year":"2001","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003217.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/art.10488","article-title":"Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al","volume":"46","author":"Cisternas","year":"2002","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jnnp.68.4.533","article-title":"Plasmapheresis in multifocal motor neuropathy: a case report","volume":"68","author":"Claus","year":"2000","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1085-9489.2005.00053.x","article-title":"Multifocal motor neuropathy during treatment with infliximab","volume":"10","author":"Cocito","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jnnp.57.Suppl.35","article-title":"Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy","volume":"57 Suppl","author":"Comi","year":"1994","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD003217.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/mus.880140913","article-title":"Conduction block in clinical practice","volume":"14","author":"Cornblath","year":"1991","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.410390308","article-title":"Sensory nerve pathology in multifocal motor neuropathy","volume":"39","author":"Corse","year":"1996","journal-title":"Annals of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003217.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/jnnp.56.11.1236","article-title":"Electrophysiological improvement after intravenous immunoglobulin in motor neuropathy with multifocal conduction block [letter]","volume":"56","author":"Cruz Martinez","year":"1993","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0030|cit30","first-page":"95","article-title":"Relapsing chronic low-dose corticosteroid responsive multifocal motor neuropathy with conduction block","volume":"37","author":"Carvalho","year":"1997","journal-title":"Electromyography and Clinical Neurophysiology"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/01.wnl.0000234063.51897.20","article-title":"Multifocal motor neuropathy with and without conduction block: a single entity?","volume":"67","author":"Delmont","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003217.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.57.7.778","article-title":"Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin","volume":"57","author":"Donaghy","year":"1994","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0960-8966(00)00191-7","article-title":"79th ENMC International Workshop: Multifocal motor neuropathy, 14-15 April 2000, Hilversum, The Netherlands","volume":"11","author":"Hughes","year":"2001","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0034|cit34","first-page":"130","article-title":"Multifocal motor neuropathy with block of nerve conduction. Report of three cases","volume":"29","author":"Estrada-Acosta","year":"1999","journal-title":"Revista de Neurologica"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2006.07.027","article-title":"Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients","volume":"56","author":"Fardet","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD003217.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.55.9.1256","article-title":"Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study","volume":"55","author":"Federico","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410300312","article-title":"Immunosuppressive treatment in multifocal motor neuropathy","volume":"30","author":"Feldman","year":"1991","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0038|cit38","first-page":"31","article-title":"Cerebrospinal fluid filtration and immunoglobulins in multifocal motor neuropathy","volume":"18","author":"Finsterer","year":"1999","journal-title":"Clinical Neuropathology"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00002371-199909000-00008","article-title":"Immunoadsorption in multifocal motor neuropathy","volume":"22","author":"Finsterer","year":"1999","journal-title":"Journal of Immunotherapy"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1529-8027.2011.00328.x","article-title":"An open label clinical trial of complement inhibition in multifocal motor neuropathy","volume":"16","author":"Fitzpatrick","year":"2011","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/(SICI)1097-4598(199906)22:6<758::AID-MUS13>3.0.CO;2-N","article-title":"Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy","volume":"22","author":"Gorson","year":"1999","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20664","article-title":"Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial","volume":"35","author":"Gorson","year":"2007","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0043|cit43","unstructured":"GRADEpro. [Computer program on www.gradepro.org] Version 2014. McMaster University 2014"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.33588\/rn.3205.2000476","article-title":"Multifocal motor neuropathy with partial nerve conduction","volume":"32","author":"Guti\u00e9rrez Ronquillo","year":"2001","journal-title":"Revista de Neurologia"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007890-199701150-00008","article-title":"Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups","volume":"63","author":"Halloran","year":"1997","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0404.1991.tb04900.x","article-title":"Chronic acquired demyelinating motor neuropathy","volume":"84","author":"Hausmanowa-Petrusewicz","year":"1991","journal-title":"Acta Neurologica Scandinavica"},{"issue":"7414","key":"10.1002\/14651858.CD003217.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0048|cit48","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"6-7","key":"10.1002\/14651858.CD003217.pub5-BIB0049|cit49","first-page":"385","article-title":"Treatment of immune deficient neuropathies with intravenous polyvalent immunoglobulins. An open study of 16 cases","volume":"149","author":"Hoang-Xuan","year":"1993","journal-title":"Revue Neurologique"},{"issue":"10","key":"10.1002\/14651858.CD003217.pub5-BIB0050|cit50","first-page":"2287","article-title":"Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"Journal of Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD003217.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF00873973","article-title":"Multifocal motor neuropathy: clinical and electrophysiological findings","volume":"243","author":"Jaspert","year":"1996","journal-title":"Journal of Neurology"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD003217.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1212\/WNL.42.3.506","article-title":"Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy","volume":"42","author":"Kaji","year":"1992","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.410330204","article-title":"Pathological findings at the site of conduction block in multifocal motor neuropathy","volume":"33","author":"Kaji","year":"1993","journal-title":"Annals of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003217.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1212\/WNL.50.1.314","article-title":"Multifocal motor neuropathy","volume":"50","author":"Komiyama","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mus.880170115","article-title":"The clinical and diagnostic role of anti-GM1 antibody testing","volume":"17","author":"Kornberg","year":"1994","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0057|cit57","first-page":"A264","article-title":"Infliximab associated motor neuropathy typically has monophasic improving course with drug discontinuation","volume":"72","author":"Kosa","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/WNL.40.1.118","article-title":"A syndrome of asymmetric limb weakness with motor conduction block","volume":"40","author":"Krarup","year":"1990","journal-title":"Neurology"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD003217.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1212\/WNL.42.3.497","article-title":"Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?","volume":"42","author":"Lange","year":"1992","journal-title":"Neurology"},{"issue":"10","key":"10.1002\/14651858.CD003217.pub5-BIB0060|cit60","first-page":"579","article-title":"Multifocal motor neuropathy with conduction block: 39 cases","volume":"153","author":"Forestier","year":"1997","journal-title":"Revue Neurologique"},{"issue":"1-2","key":"10.1002\/14651858.CD003217.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2008.02.022","article-title":"The clinical value of therapeutic plasma exchange in multifocal motor neuropathy","volume":"271","author":"Lehmann","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"10.1002\/14651858.CD003217.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","article-title":"Multifocal demyelinating neuropathy with persistent conduction block","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD003217.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/(SICI)1097-4598(199912)22:12<1738::AID-MUS21>3.0.CO;2-2","article-title":"Multifocal motor neuropathy and Lewis Sumner syndrome: two distinct entities [letter; comment]","volume":"22","author":"Lewis","year":"1999","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy","volume":"66","author":"Lozeron","year":"2009","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.57.Suppl.46","article-title":"Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy","volume":"November 57 Sup","author":"L\u00e9ger","year":"1994","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"Pt 1","key":"10.1002\/14651858.CD003217.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/124.1.145","article-title":"Intravenous immunoglobulin therapy in multifocal motor neuropathy: A double-blind, placebo-controlled study","volume":"124","author":"L\u00e9ger","year":"2001","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jnnp.2007.121756","article-title":"Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients","volume":"79","author":"L\u00e9ger","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.66.2.197","article-title":"Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies","volume":"66","author":"Martina","year":"1999","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1196\/annals.1254.064","article-title":"Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study","volume":"998","author":"Meriggioli","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/jnnp.63.6.765","article-title":"Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy","volume":"63","author":"Meucci","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD003217.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/(SICI)1097-4598(199912)22:12<1739::AID-MUS22>3.0.CO;2-Z","article-title":"Multifocal motor neuropathy and Lewis Sumner syndrome: a clinical spectrum","volume":"22","author":"Mezaki","year":"1999","journal-title":"Muscle & Nerve"},{"issue":"12","key":"10.1002\/14651858.CD003217.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.neurol.2011.02.042","article-title":"[Improvement of severe and intravenous immunoglobulin-dependent multifocal motor neuropathy with conduction block after long-term rituximab]","volume":"167","author":"Michaud","year":"2011","journal-title":"Revue Neurologique (Paris)"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-510X(01)00478-6","article-title":"Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis","volume":"185","author":"Mowzoon","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"10.1002\/14651858.CD003217.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00415-003-0131-3","article-title":"Efficacy of cyclosporine in multifocal motor neuropathy","volume":"250","author":"Nemni","year":"2003","journal-title":"Journal of Neurology"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD003217.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.43.3_Part_1.537","article-title":"High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy","volume":"43","author":"Nobile-Orazio","year":"1993","journal-title":"Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD003217.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(01)00266-1","article-title":"Multifocal motor neuropathy","volume":"115","author":"Nobile-Orazio","year":"2001","journal-title":"Journal of Neuroimmunology"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jnnp.72.6.761","article-title":"Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block","volume":"72","author":"Nobile-Orazio","year":"2002","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1529-8027.2009.00233.x","article-title":"Oral methotrexate as adjunctive therapy in patients with multifocal motor neuropathy on chronic IVIg therapy","volume":"14","author":"Nobile-Orazio","year":"2009","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0079|cit79","first-page":"362","article-title":"Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy?","volume":"2","author":"Oh","year":"1997","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.55.5.735-e","article-title":"Multifocal inflammatory demyelinating neuropathy: A distinct clinical entity?","volume":"55","author":"Oh","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mus.10317","article-title":"Consensus criteria for the diagnosis of multifocal motor neuropathy","volume":"27","author":"Olney","year":"2003","journal-title":"Muscle and Nerve"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"570","DOI":"10.5014\/ajot.57.5.570","article-title":"Adult norms for a commercially available Nine Hole Peg Test for finger dexterity","volume":"57","author":"Oxford Grice","year":"2003","journal-title":"American Journal of Occupational Therapy"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<243::AID-MUS14>3.0.CO;2-2","article-title":"Multifocal motor neuropathy without overt conduction block","volume":"21","author":"Pakiam","year":"1998","journal-title":"Muscle and Nerve"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0084|cit84","first-page":"167 (abstract)","article-title":"Pure motor neuropathy with multifocal conduction block masquerading as motor neuron disease","volume":"8","author":"Parry","year":"1985","journal-title":"Muscle and Nerve"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mus.880110203","article-title":"Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease","volume":"11","author":"Parry","year":"1988","journal-title":"Muscle and Nerve"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.410270314","article-title":"Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of anti-glycolipid antibodies","volume":"27","author":"Pestronk","year":"1990","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0088|cit88","unstructured":"Pestronk A Neuromuscular Disease Center, Washington University School of Medicine http:\/\/www.neuro.wustl.edu\/neuromuscular"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jnnp.74.4.485","article-title":"Treatment of IgM antibody associated polyneuropathies using rituximab","volume":"74","author":"Pestronk","year":"2003","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/rheumatology\/kel336","article-title":"Mycophenolate mofetil treatment in resistant myositis","volume":"46","author":"Pisoni","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/(SICI)1097-4598(199703)20:3<347::AID-MUS12>3.0.CO;2-Y","article-title":"Multifocal motor neuropathy presenting as ophthalmoplegia","volume":"20","author":"Pringle","year":"1997","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000095139","article-title":"Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study","volume":"56","author":"Radziwill","year":"2006","journal-title":"European Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1529-8027.2009.00232.x","article-title":"Interferon beta-1a as adjunctive treatment for multifocal motor neuropathy: an open label trial","volume":"14","author":"Radziwill","year":"2009","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0094|cit94","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ana.410280206","article-title":"A computer simulation of conduction block: effects produced by actual block versus interphase cancellation","volume":"28","author":"Rhee","year":"1990","journal-title":"Annals of Neurology"},{"issue":"10","key":"10.1002\/14651858.CD003217.pub5-BIB0096|cit96","first-page":"2079","article-title":"Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis","volume":"31","author":"Richette","year":"2004","journal-title":"Journal of Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD003217.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/01.WNL.0000158681.29117.8B","article-title":"Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers","volume":"64","author":"Richez","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/rheumatology\/keh439","article-title":"Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy","volume":"44","author":"Rodriguez-Escalera","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1002\/14651858.CD003217.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1212\/01.WNL.0000098996.02934.86","article-title":"Chronic neuropathy with IgM anti-ganglioside antibodies:lack of response to rituximab","volume":"61","author":"Rojas-Garcia","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.33588\/rn.3205.2000476","article-title":"Multifocal motor neuropathy with partial block nerve conduction","volume":"32","author":"Gutierrez Ronquillo","year":"2001","journal-title":"Revista de Neurologica"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000116045","article-title":"Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia","volume":"25","author":"Roth","year":"1986","journal-title":"European Journal of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003217.pub5-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1212\/01.WNL.0000145706.04340.25","article-title":"Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg","volume":"63","author":"Ruegg","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","article-title":"Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome","volume":"22","author":"Saperstein","year":"1999","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/135245859900500406","article-title":"The Guy's Neurological Disability Rating Scale (GNDS): a new disability measure for multiple sclerosis","volume":"5","author":"Sharrack","year":"1999","journal-title":"Multiple Sclerosis"},{"issue":"9","key":"10.1002\/14651858.CD003217.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1212\/01.WNL.0000142974.81103.95","article-title":"Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy","volume":"63","author":"Singer","year":"2004","journal-title":"Neurology"},{"issue":"17","key":"10.1002\/14651858.CD003217.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/01.wnl.0000277697.55288.d0","article-title":"Multifocal motor neuropathy: the diagnostic spectrum and response to treatment","volume":"69","author":"Slee","year":"2007","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003217.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nmd.2009.04.013","article-title":"Beneficial effect of rituximab monotherapy in multifocal motor neuropathy","volume":"19","author":"Stieglbauer","year":"2009","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/archneur.1994.00540140104020","article-title":"Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish treatable disease","volume":"51","author":"Tan","year":"1994","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1212\/WNL.47.4.951","article-title":"The sensitivity and specificity of anti-GM1 antibody testing","volume":"47","author":"Taylor","year":"1996","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<900::AID-MUS9>3.0.CO;2-Y","article-title":"Natural history of 46 patients with multifocal motor neuropathy with conduction block","volume":"23","author":"Taylor","year":"2000","journal-title":"Muscle and Nerve"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s10067-006-0317-z","article-title":"Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment","volume":"26","author":"Tektonidou","year":"2007","journal-title":"Clinical Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.WNL.0000110185.23464.A1","article-title":"How long is IVIg effective in multifocal motor neuropathy?","volume":"62","author":"Terenghi","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1085-9489.2006.00065.x","article-title":"Circulating levels of cytokines and their modulation by intravenous immunoglobulin in multifocal motor neuropathy","volume":"11","author":"Terenghi","year":"2006","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0960-8966(01)00311-X","article-title":"Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association","volume":"12","author":"Toscano","year":"2002","journal-title":"Neuromuscular Disorders"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1468-1331.2002.00478.x","article-title":"Mycophenolate in treatment-resistant inflammatory neuropathies","volume":"9","author":"Umapathi","year":"2002","journal-title":"European Journal of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD003217.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/brain\/awl197","article-title":"Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve","volume":"129","author":"Asseldonk","year":"2006","journal-title":"Brain"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jnnp.59.3.248","article-title":"Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study","volume":"59","author":"Berg","year":"1995","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003217.pub5-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.48.4.1135","article-title":"Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy","volume":"48","author":"Berg","year":"1997","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1002\/14651858.CD003217.pub5-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/brain\/121.3.421","article-title":"The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy","volume":"121","author":"Berg","year":"1998","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.54.1.26","article-title":"Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?","volume":"54","author":"Berg-Vos","year":"2000","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003217.pub5-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1212\/WNL.54.7.1518","article-title":"Treatment of multifocal motor neuropathy with interferon-beta1a","volume":"54","author":"Berg-Vos","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003217.pub5-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/1531-8249(200012)48:6<919::AID-ANA13>3.0.CO;2-J","article-title":"Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment","volume":"48","author":"Berg-Vos","year":"2000","journal-title":"Annals of Neurology"},{"issue":"Pt 8","key":"10.1002\/14651858.CD003217.pub5-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/brain\/awf193","article-title":"Multifocal motor neuropathy: long term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment","volume":"125","author":"Berg-Vos","year":"2002","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.880120106","article-title":"Motor neuropathy with multifocal conduction blocks","volume":"12","author":"Bergh","year":"1989","journal-title":"Muscle & Nerve"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/WNL.48.5.1218","article-title":"Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy","volume":"48","author":"Es","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0127|cit127","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004429.pub2","article-title":"Intravenous immunoglobulin for multifocal motor neuropathy","author":"Schaik","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD003217.pub5-BIB0128|cit128","first-page":"802","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of multifocal motor neuropathy","volume":"13","author":"Schaik","year":"2006","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"5","key":"10.1002\/14651858.CD003217.pub5-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD003217.pub5-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.nmd.2013.06.006","article-title":"196th ENMC international workshop: outcome measures in inflammatory peripheral neuropathies 8-10 February 2013, Naarden, The Netherlands","volume":"23","author":"Vanhoutte","year":"2013","journal-title":"Neuromuscular Disorders"},{"issue":"Pt 9","key":"10.1002\/14651858.CD003217.pub5-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/brain\/awh222","article-title":"Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome","volume":"127","author":"Viala","year":"2004","journal-title":"Brain"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1468-1331.1996.tb00210.x","article-title":"High-dose intravenous immunoglobulin therapy improved muscle strength in a patient with multifocal motor neuropathy and antibodies against the gycolipid LK1","volume":"3","author":"Vrethem","year":"1996","journal-title":"European Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003217.pub5-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/01.WNL.0000140497.85952.FA","article-title":"Multifocal motor neuropathy: decrease in conduction blocks and reinnvervation with long-term IVIg","volume":"63","author":"Vucic","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","article-title":"Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies","volume":"6","author":"Willison","year":"1999","journal-title":"European Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0135|cit135","first-page":"220","article-title":"Treatment of multifocal motor neuropathy with a high dosage of intravenous immunoglobulin","volume":"16","author":"Yuki","year":"1993","journal-title":"Muscle and Nerve"},{"key":"10.1002\/14651858.CD003217.pub5-BIB0136|cit136","first-page":"A264","article-title":"Infliximab associated motor neuropathy typically has monophasic improving course with drug discontinuation","volume":"72","author":"Kosa","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003217.pub5-BIB0137|cit137","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003217","article-title":"Immunosuppressive treatment for multifocal motor neuropathy","author":"Umapathi","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003217.pub5-BIB0138|cit138","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003217.pub2","article-title":"Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy","author":"Umapathi","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003217.pub5-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003217.pub3","article-title":"Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy","author":"Umapathi","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003217.pub5\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T08:01:46Z","timestamp":1642320106000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003217.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,4]]},"references-count":139,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003217.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,4]]}}}